P

Inventor

EVANS CATHERINE A

US40 patents
⚠️ This page may combine multiple inventors who share the name “EVANS CATHERINE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INFINITY PHARMACEUTICALS INC

26 patents
US9181221B2Nov 10, 2015

Chemical compounds, compositions and methods for kinase modulation

INFINITY PHARMACEUTICALS INC64 citations98
US9359365B2Jun 7, 2016

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC24 citations94
US8940742B2Jan 27, 2015

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC35 citations94
US9388183B2Jul 12, 2016

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC19 citations93
US9255108B2Feb 9, 2016

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC21 citations93
US9115141B2Aug 25, 2015

Substituted isoquinolinones and methods of treatment thereof

INFINITY PHARMACEUTICALS INC27 citations93
US9775844B2Oct 3, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC13 citations92
US10329299B2Jun 25, 2019

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC7 citations84
US9828377B2Nov 28, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC4 citations84
US9708348B2Jul 18, 2017

Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof

INFINITY PHARMACEUTICALS INC13 citations84
US8349814B2Jan 8, 2013

Inhibitors of fatty acid amide hydrolase

INFINITY PHARMACEUTICALS INC3 citations74
US7947663B2May 24, 2011

Inhibitors of fatty acid amide hydrolase

INFINITY PHARMACEUTICALS INC6 citations74
US11541059B2Jan 3, 2023

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC2 citations73
US10759806B2Sep 1, 2020

Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors

INFINITY PHARMACEUTICALS INC3 citations73
US9751888B2Sep 5, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC2 citations73
US9605003B2Mar 28, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC3 citations73
US9546180B2Jan 17, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC2 citations73
US9108989B2Aug 18, 2015

Inhibitors of fatty acid amide hydrolase

INFINITY PHARMACEUTICALS INC1 citations63
US8629125B2Jan 14, 2014

Inhibitors of fatty acid amide hydrolase

INFINITY PHARMACEUTICALS INC3 citations63
US12152032B2Nov 26, 2024

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC0 citations62
US10941162B2Mar 9, 2021

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC0 citations62
US10919914B2Feb 16, 2021

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC0 citations52
US10253047B2Apr 9, 2019

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC0 citations52
US9738644B2Aug 22, 2017

Chemical compounds, compositions and methods for kinase modulation

INFINITY PHARMACEUTICALS INC0 citations52
US9718815B2Aug 1, 2017

Heterocyclic compounds and uses thereof

INFINITY PHARMACEUTICALS INC0 citations52
US8802119B2Aug 12, 2014

Inhibitors of fatty acid amide hydrolase

INFINITY PHARMACEUTICALS INC0 citations52

CASTRO ALFREDO C

4 patents

BEHNKE MARK L

4 patents

REN PINGDA

2 patents

IKENA ONCOLOGY INC

2 patents

KEROS THERAPEUTICS INC

1 patent

ADAMS JULIAN

1 patent